Key result
Maternal Sjögren’s disease is linked to a ~338% higher rate of minor CHDs.
Why the study?
While newborns of mothers with autoimmune systemic connective tissue disease have a higher incidence of major congenital heart defects, less is known about associations with less severe newborn cardiac abnormalities.
Does maternal autoimmune connective tissue disease affect cardiac structure and function or increase the risk of minor congenital heart defects in newborns?
Observational (n=25,590)
Does maternal autoimmune connective tissue disease affect cardiac structure and function or increase the risk of minor congenital heart defects in newborns?
Absolute Event Rate: 33.3% vs 7.6%
p-value: p=0.03
Overall maternal autoimmune connective tissue disease is not associated with significant newborn cardiac structural or functional abnormalities, though maternal Sjögren's disease may increase the risk of minor congenital heart defects.
Should not yet change neonatal screening; leaves open confirmation and long-term meaning of more frequent minor CHDs.
Introduction Newborns of mothers with autoimmune systemic connective tissue disease (CTD) have a higher incidence of major congenital heart defects (CHDs) compared to unexposed newborns. Less is known about the association between maternal CTD and less severe cardiac abnormalities in the newborn. Methods We analysed prospectively collected echocardiographic data from the Copenhagen Baby Heart Study (CBHS), comparing newborns exposed to maternal CTD with those who were not exposed. Maternal autoimmune CTD diagnoses were identified through the National Patient Register and validated by medical record review. Outcome measures included minor CHDs (atrial and ventricular septal defects, bicuspid aorta valve and patent ductus arteriosus), as well as cardiac dimensions and function. Results In total 25,590 newborns underwent echocardiography in the CBHS, of whom 57 (0.22%) were born to mothers with CTD. When comparing newborns of mothers with overall CTD to non-exposed newborns, we found no differences in structural and functional cardiac parameters. Minor CHDs were more common in newborns born to mothers with Sjögren’s disease (n = 3, 33.3%) than in unexposed newborns (n = 1,945, 7.6%, p = 0.03). Conclusions In this large population-based study, we did not observe consistent associations between overall maternal CTD and cardiac structure or function in the infant, although minor CHD were more common in newborns exposed to maternal Sjögren’s disease. Findings should be interpreted with caution, considering the small sample size of exposed newborns and potential underrepresentation of major CHD due to standard clinical management practices.
No takes yet. Share an insight, caveat, or question.
Neumann et al. (2026) conducted an observational in Maternal autoimmune connective tissue disease (n=25,590). Maternal autoimmune connective tissue disease vs. Unexposed newborns was evaluated on Minor CHDs (atrial and ventricular septal defects, bicuspid aorta valve and patent ductus arteriosus) (p=0.03). Maternal connective tissue disease was not associated with infant cardiac abnormalities, but minor congenital heart defects were more common with maternal Sjögren’s disease (33.3% vs 7.6%, p=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: